From: Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer
FTV | FAPI-46/dual-tracer PET/CT (ml, mean ± SD) | FDG-PET/CT (ml, mean ± SD) | Wilcoxon signed-rank test; Pearson’s correlation |
---|---|---|---|
FTVtotal | 77.04 ± 84.03 | 58.09 ± 76.20 | p < 0.001; r = 0. 0837 |
FTVtumor | 49.17 ± 63.67 | 32.82 ± 49.71 | p = 0.002; r = 0.703 |
FTVmetastases | 33.69 ± 74.64 | 40.03 ± 82.03 | p = 0.008; r = 0.992 |